Patents by Inventor Chuanliang JIANG

Chuanliang JIANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11767286
    Abstract: Provided in the present invention are a phenylpropionate compound, a preparation method for same, and applications. The phenylpropionate compound has the structure as represented by formula I. The phenylpropionate compound of the present invention, a pharmaceutically acceptable salt, a solvate, a prodrug, and a tautomer or stereochemical isomer or pharmaceutical composition of the compound provide improved anti-inflammatory and antiplatelet effects and, at the same time, provide an extended time window for treatment, are free of obvious side effects, safe and effective, applicable in an antithrombus, anti-inflammatory, and cerebral stroke treating medicament, and have broad application prospects.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: September 26, 2023
    Assignee: SUZHOU PHARMAVAN CO., LTD
    Inventors: Qian Liu, Yunsen Li, Shiping Deng, Yuan Gao, Shanning Lou, Yunhui Yu, Chuanliang Jiang
  • Patent number: 11602514
    Abstract: The present application provides a medicament having an anti-inflammatory bowel disease function, and a preparation method therefor and an application thereof. The medicament has a structure as represented in formula I or formula II. The medicament and a pharmaceutically acceptable salt, a solvate, a prodrug, a tautomer, a stereoisomer, or a pharmaceutical composition thereof provided by the present application have a good effect on inflammatory bowel diseases, can be used for preparing medicaments for treating the inflammatory bowel diseases, and have important clinical significance and wide application prospects.
    Type: Grant
    Filed: July 28, 2018
    Date of Patent: March 14, 2023
    Assignee: SUZHOU PHARMAVAN CO., LTD
    Inventors: Shiping Deng, Yu Cao, Zhi Li, Yunhui Yu, Kui Zhang, Minjie Zhang, Gaogang Yuan, Tao Xu, Gang Yu, Chuanliang Jiang
  • Patent number: 11406622
    Abstract: A glaucocalyxin A derivative, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof and uses thereof in the preparation of drugs for treating psoriasis.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: August 9, 2022
    Assignee: SUZHOU PHARMAVAN CO., LTD.
    Inventors: Haimei Feng, Rensen Zhou, Yunhui Yu, Chuanliang Jiang, Shiping Deng, Qian Liu
  • Publication number: 20210015780
    Abstract: The present application provides a medicament having an anti-inflammatory bowel disease function, and a preparation method therefor and an application thereof. The medicament has a structure as represented in formula I or formula II. The medicament and a pharmaceutically acceptable salt, a solvate, a prodrug, a tautomer, a stereoisomer, or a pharmaceutical composition thereof provided by the present application have a good effect on inflammatory bowel diseases, can be used for preparing medicaments for treating the inflammatory bowel diseases, and have important clinical significance and wide application prospects.
    Type: Application
    Filed: July 28, 2018
    Publication date: January 21, 2021
    Applicant: SUZHOU PHARMAVAN CO., LTD
    Inventors: Shiping DENG, Yu CAO, Zhi LI, Yunhui YU, Kui ZHANG, Minjie ZHANG, Gaogang YUAN, Tao XU, Gang YU, Chuanliang JIANG
  • Publication number: 20200331842
    Abstract: Provided in the present invention are a phenylpropionate compound, a preparation method for same, and applications. The phenylpropionate compound has the structure as represented by formula I. The phenylpropionate compound of the present invention, a pharmaceutically acceptable salt, a solvate, a prodrug, and a tautomer or stereochemical isomer or pharmaceutical composition of the compound provide improved anti-inflammatory and antiplatelet effects and, at the same time, provide an extended time window for treatment, are free of obvious side effects, safe and effective, applicable in an antithrombus, anti-inflammatory, and cerebral stroke treating medicament, and have broad application prospects.
    Type: Application
    Filed: January 19, 2018
    Publication date: October 22, 2020
    Applicant: SUZHOU PHARMAVAN CO., LTD
    Inventors: Qian LIU, Yunsen LI, Shiping DENG, Yuan GAO, Shanning LOU, Yunhui YU, Chuanliang JIANG
  • Publication number: 20200261375
    Abstract: Disclosed is the use of (+)-2-borneol in the preparation of a drug for promoting the upregulation of the expression of sphingosine kinase-1 and/or BDNF (a brain-derived neurotrophic factor). Herein, (+)-2-borneol can be used to prepare a drug for promoting the upregulation of the expression of the sphingosine kinase-1 and/or the brain-derived neurotrophic factor. The drug can induce astrocyte spreading and migration, oligodendrocyte differentiation and survival, and neurite growth and nerve regeneration, and can promote the upregulation of the expression of the brain-derived neurotrophic factor, promote the survival of neurons and the growth of axons, inhibit the expansion of the infarct volume, and achieve the effect of repairing damage at the site of an immediate injury while preventing further expansion of the infarct area to completely treat brain damage, so that the long-term therapeutic effect thereof is significantly improved.
    Type: Application
    Filed: June 7, 2017
    Publication date: August 20, 2020
    Inventors: Yunsen LI, Shiping DENG, Yong LI, Chuanliang JIANG, Yunhui YU
  • Publication number: 20200061029
    Abstract: A glaucocalyxin A derivative, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof and uses thereof in the preparation of drugs for treating psoriasis.
    Type: Application
    Filed: February 2, 2018
    Publication date: February 27, 2020
    Inventors: Haimei FENG, Rensen ZHOU, Yunhui YU, Chuanliang JIANG, Shiping DENG, Qian LIU